Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway

Published:2024-06 Issue: Volume:268 Page:63-78
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

Sa Pratikshya,Singh Priya,Panda Sudhakar,Swain Rajeeb K.,Dash Rupesh,Sahoo Sanjeeb Kumar^ORCID

Funder

Department of Biotechnology, Ministry of Science and Technology, India

Council of Scientific and Industrial Research, India

Regional Centre for Biotechnology

Life Sciences Institute

Publisher

Elsevier BV

Reference72 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases;Wang;Chin J Cancer,2013

3. Extracellular Vesicle-Mediated Chemoresistance in Oral Squamous Cell Carcinoma;Law;Front Mol Biosci,2021

4. Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome;Ju;Cancer Commun,2021

5. Predicting the prognosis of oral squamous cell carcinoma after first recurrence;Kernohan;Arch Otolaryngol Head Neck Surg,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP